person

Joris H.

Country
The Netherlands
Department
Emergency Department

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 8 partner sites.

Specializations

Cardiovascular Medicine

Investigator concentrates on acute and chronic heart and vessel disorders, such as acute myocardial infarction and atrial fibrillation, as well as peripheral circulation disease.

  • Acute coronary syndromes
  • Heart failure with renal impairment
  • Peripheral arterial disease
  • Stroke prevention in atrial fibrillation
  • Lipid‑lowering strategies for atherosclerotic disease

Efforts target reduction of major adverse cardiovascular events and enhancement of long‑term cardiovascular health.

Oncology

Research activities span solid and hematologic malignancies, including non‑small cell lung cancer, breast cancer, and multiple myeloma.

  • Targeted therapy in lung cancer
  • Immunotherapy for urothelial carcinoma
  • HER2‑positive esophageal and gastric cancers
  • Relapsed/refractory lymphoma
  • Adjuvant treatment strategies in early‑stage cancers

Focus is on improving survival outcomes and defining optimal combination regimens.

Metabolic & Endocrine Disorders

Investigator addresses metabolic risk factors, notably type 2 diabetes mellitus and dyslipidaemia, alongside obesity‑related conditions.

  • Glycaemic control in high‑risk diabetic patients
  • Management of severe hypertriglyceridaemia
  • Statin intolerance and alternative lipid‑lowering agents
  • Obesity and overweight interventions
  • Primary prevention of atherosclerotic cardiovascular disease

Goals include mitigating cardiovascular risk through metabolic optimisation.

Pulmonary & Critical Care

Clinical focus includes acute respiratory conditions such as severe asthma with eosinophilic phenotype and infectious pulmonary diseases.

  • Management of eosinophilic severe asthma
  • Treatment of community‑acquired pneumonia
  • Ventilator weaning strategies
  • Respiratory distress oxygen‑saturation targets
  • Chronic obstructive pulmonary disease exacerbations

Research aims to improve respiratory outcomes and reduce intensive care burden.

Hematology & Immunology

Investigator engages in studies of blood‑cell malignancies, including acute myeloid leukaemia and chronic lymphocytic leukaemia, as well as immune‑mediated disorders.

  • Novel agents for acute myeloid leukaemia
  • Combination regimens in chronic lymphocytic leukaemia
  • Therapies for myelodysplastic syndromes
  • Immune modulation in multiple sclerosis
  • Management of autoimmune inflammatory bowel disease

Efforts target disease modification and durable remission in hematologic and immune conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.